Wider cell contacts may prevent enzyme exclusion, impair clearance and renew inflammation
Persistent surface geometry may let the phosphate-removing enzyme CD45 remain in macrophage contacts, impairing clearance and renewing inflammation. No dependence on connector length despite a verified change in membrane spacing would reject this explanation.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Lens
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Physical property of tissue
Cell surface geometry
The physical arrangement, height and density of molecules on cell surfaces
Where this hypothesis actsContacts between macrophages and tissue cells or their remnants after prior damage
Hypotheses on this target 1
Remodelling1
Composition restoration
Load normalisation
Direct measurement

What is proposed
Remodelling
Restore intermembrane spacing that permits complete engulfment
With whatPhysical or surgical intervention
HowChange the length of an inert molecular linker while keeping ligand density, receptor affinity, cell composition and the current environment constant
Possible result
Possible restoration of clearance and prevention of recurrent inflammation without changing nuclear programmes
From the recordВосстановление подходящего расстояния в фагоцитарном контакте должно разорвать цикл неполной очистки и повторного повреждения

Enzyme
CD45
A cell-surface phosphatase that removes activating phosphate groups
Where this hypothesis actsMacrophage contacts with tissue cells and their remnants during engulfment
Hypotheses on this target 1
Inhibition
Activation
Lower level
Higher level
Replacement
Protection from degradation
Cofactor removal
Synthesis suppression
Function preservation
What is proposed
Exclude CD45 from the phagocytic contact
With whatControlled genetic model
HowShorten intermembrane spacing to sterically exclude CD45; shorten its extracellular portion as a causal test of that exclusion
Possible result
Possible restoration of receptor phosphorylation and completed engulfment
From the recordПри h>d стерическая цена снижает присутствие фосфатазы в контакте.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Inflammation may return because damaged material remains difficult to remove even after its surroundings recover. The unexpected move is to place the lasting reminder of injury in the physical arrangement of molecules on cell surfaces, rather than solely in persistent activity inside cells. That is a proposal generated by this pipeline, not a measured explanation of recurrent inflammation.
- Earlier injury is proposed to leave a lasting change in the height and density of surface molecules on tissue cells and their remains.
- Those altered surfaces would hold the membrane of an approaching macrophage farther from the material it needs to remove.
- The wider contact would switch CD45 from being excluded from the recognition area to remaining inside it.
- CD45 remaining in the contact would remove activating phosphate groups and weaken the signals needed for engulfment.
- Incomplete engulfment would allow cell material to accumulate again and restart inflammation after surrounding conditions recover.
- Restoring a close contact is predicted to exclude CD45, restore removal, and interrupt renewed damage.
A narrow gap beneath a door keeps a bulky object out; raising the door lets that same object pass underneath. Here, widening the gap would admit something that interferes with cleanup.
Where the picture breaks: Cell surfaces are flexible and crowded, and CD45 moves within a membrane rather than underneath a door. The picture explains size-dependent access, but it does not establish that injury leaves the gap widened or that changing it prevents inflammation.
- Master questionstep 01 of 04
Several processes involved in aging may reinforce one another, so changing a shared cause could benefit several body systems.
Rests on: The supplied goal explicitly seeks shared causes whose precise modification might produce benefits across systems.
Stated in the chain - Goal pillarstep 02 of 04
Recovery should remain stable instead of giving way to a lasting damaged state.
Rests on: The search for a shared cause is narrowed to the ability to sustain recovery.
AssumptionThe selection assumes that failure to sustain recovery is a useful shared target for the aging processes in the goal. The supplied goal does not establish that connection.
- Gap questionstep 03 of 04
Inflammation returning after the surroundings recover could reflect lasting changes in tissue cells, in blood-forming precursor cells that produce new blood cells, or in reinforcement between those groups. Separate and combined temporary suppression of their persistent activity is proposed to distinguish these possibilities.
Rests on: Stable recovery makes renewed inflammation a relevant failure to explain, but the preceding stage names no particular cells or persistent activities.
LeapThe chain does not supply the bridge from recovery in general to recurrent inflammation specifically, or the basis for selecting these two cellular sources and their interaction as the alternatives to separate.
- Hypothesisstep 04 of 04
Earlier injury is proposed to leave lasting changes in the height and density of molecules on tissue cells and their remains. These changes would widen contact with a macrophage, an immune cell that engulfs material, allowing CD45, a surface enzyme that removes phosphate groups involved in signaling, to remain where recognition occurs. Continued removal of activating phosphate groups would weaken engulfment, allowing material to accumulate again and inflammation to return.S1
Rests on: The gap question supplies the problem of inflammation returning after recovery of the surroundings. S1, a 2018 Cell study, supports a central physical link: engulfment was impaired when target molecules held attached antibodies more than 10 nanometers from a reconstructed target surface. That finding concerns antibody-coated targets; it does not establish lasting injury-induced surface changes, removal of natural cell remains, or renewed inflammation.
Supported by literature
What is carried, and what is not. One screened source, S1 in Cell in 2018, directly supports the central connection between target geometry and engulfment in an antibody-coated target system; it does not establish the proposed persistent changes after injury or their role in recurrent inflammation. The other screened sources provide background, and none establishes the proposed sequence from prior injury through altered spacing to renewed inflammation and durable recovery.S1
Where the reasoning is carried by something unstated · 2
- Goal pillar. The selection assumes that failure to sustain recovery is a useful shared target for the aging processes in the goal. The supplied goal does not establish that connection.
- Gap question. The chain does not supply the bridge from recovery in general to recurrent inflammation specifically, or the basis for selecting these two cellular sources and their interaction as the alternatives to separate. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Changing connector length could be credited with changing contact spacing even if it also changes how readily recognition molecules bind the target. What closes it: The specified controls must hold constant the number of binding molecules per surface area, their binding strength, cell composition, and current surroundings. Actual membrane spacing, CD45 presence at the contact, activating phosphate groups on the recognition protein, and completed engulfment must be measured together; connector length alone does not establish the intervening sequence.
- Successful engulfment of engineered, antibody-coated targets could be mistaken for evidence that the same mechanism clears natural dead-cell material and prevents inflammation from returning. What closes it: The proposed follow-up on natural cell material must establish the persistent surface alteration after injury and connect corrected spacing to completed removal, reduced reaccumulation, and subsequent inflammation after surrounding conditions normalize. Success on engineered targets establishes only the narrower result.
- Reduced inflammation after shortening the contact could be mistaken for evidence that surface geometry stores the lasting effect of injury, although the intervention might improve cleanup while another proposed source of inflammation remains active. What closes it: The predicted loss of benefit when CD45 is shortened must accompany the spacing result. The persistent activity inside cells must also remain unchanged, as the prediction requires, and the competing explanations must be assessed: fused tissue and immune cells, immune detection of the cell's own ribonucleic acid, or inflammatory fragments of the structural material between cells. The supplied design does not specify tests that exclude all three.
What would make this wrong. The distinctive geometric explanation would be rejected if confirmed changes in membrane spacing, under the specified matched conditions, failed to produce the predicted linked changes in CD45 presence, activating phosphate groups, and completed engulfment. Its explanation of recurrent inflammation would also fail if spacing correction restored removal of natural cell material but inflammation still returned under normalized surroundings.
What it would change. If the full proposal held, a physical feature of damaged material could preserve the conditions for renewed inflammation after surrounding signals and tissue stiffness recover. Work seeking a shared intervention against aging would then need to consider whether restoring effective removal can make recovery durable across affected systems. Even that result would not establish a benefit across organs, longer life, or effectiveness in humans; the supplied material gives no defined species, tissue, or follow-up duration for testing the complete sequence.
Sources read · 8
Size-Dependent Segregation Controls Macrophage Phagocytosis of Antibody-Opsonized Targets. · 2018
“Using a reconstituted model of antibody-opsonized target cells, we find that phagocytosis is dramatically impaired for antigens that position antibodies >10 nm from the target surface.”
Does not settle: Источник показывает этот механизм для антитело-опсонизированных реконструированных мишеней, а также инженерных и опухолевых антигенов. Он не устанавливает, что предшествующее повреждение тканей создаёт устойчивую геометрию поверхности, что остатки клеток повторно накапливаются и возвращают воспаление после нормализации сигналов и жёсткости среды, или что восстановление расстояния стабилизирует SPV_6.
Syndecan-1 modulates the motility and resolution responses of macrophages. · Arteriosclerosis, thrombosis, and vascular biology · 2015
“These results demonstrate that defective motility in Sdc-1 −/− macrophages promotes a persistent inflammatory state with relevance to the pathogenesis of atherosclerosis.”
Does not settle: It does not establish persistent injury-induced surface geometry on tissue cells or debris, membrane-contact distance, CD45 exclusion, impaired phagocytosis, recurrent inflammation after soluble signals or stiffness normalize, or restoration of contact spacing as an intervention.
Leucocyte activation markers in clinical practice. · Clinical chemistry and laboratory medicine · 1999
“The response against tissue injury and infection begins with the early activation of molecular and cellular elements of the inflammatory and immune response.”
Does not settle: This abstract does not establish persistent changes in surface geometry, membrane spacing at macrophage contacts, CD45 exclusion or activity, phagocytic clearance, recurrent inflammation after soluble signals normalize, or SPV_6 stabilization.
Targeting immune-hemodynamic coupling in early diabetic kidney disease: Mechanisms, biomarkers, and therapeutic opportunities. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
“The downstream consequences are tightly interlinked, comprising endothelial dysfunction, glycocalyx injury, an unbalanced nitric oxide/endothelin axis, tubuloglomerular feedback disruption, and maladaptive arteriolar remodeling.”
Does not settle: Источник не устанавливает устойчивое изменение геометрии поверхности после повреждения, расстояние в контакте макрофага с клеточным материалом, исключение CD45, эффективность фагоцитоза, повторное накопление материала или возврат воспаления.
Systemic Monocyte Chemotactic Protein-1 Inhibition Modifies Renal Macrophages and Restores Glomerular Endothelial Glycocalyx and Barrier Function in Diabetic Nephropathy. · The American journal of pathology · 2017
“We show that MCP-1 inhibition restores glomerular endothelial glycocalyx and barrier function and reduces tissue inflammation in the presence of ongoing diabetic injury, suggesting a therapeutic potential for NOX-E36 in diabetic nephropathy.”
Does not settle: Источник оставляет открытыми геометрию фагоцитарного контакта, исключение CD45, поглощение клеточного материала, его накопление и повторное воспаление. Описаны только мыши с диабетической нефропатией.
Induction of heat-stable antigen expression by phagocytosis is involved in in vitro activation of unprimed CTL by macrophages. · Journal of immunology (Baltimore, Md. : 1950) · 1996
“Other proteins appear to be regulated by a similar mechanism, because the surface expression of the CD45 isoform B220, of IL-2R, and of CD26 also increased immediately following ingestion of beads by M phi.”
Does not settle: Остаются открытыми геометрия фагоцитарного контакта, исключение CD45, поглощение клеточного материала, устойчивость поверхностных изменений после повреждения и повторное воспаление.
Disentangling neuroimmune landscapes across peripheral activation paradigms resolves divergent glial state programs. · Research square · 2026
“In contrast, LPS_Low_Repeated preserved homeostatic genes and enhanced phagocytic markers including Clec7a, Cx3cr1, and Mrc1 , suggesting a reorientation of microglia toward clearance functions.”
Does not settle: Источник не изучает геометрию поверхности, межмембранное расстояние, исключение CD45 из фагоцитарного контакта, неполное поглощение материала или повторное воспаление.
In vitro models of microglia: a comparative study. · Scientific reports · 2025
“These findings demonstrate a lack of direct translatability of results between different microglia models and highlight the importance of cross-validating findings.”
Does not settle: Источник не устанавливает влияние геометрии поверхности или межмембранного расстояния на исключение CD45, фагоцитоз, клиренс материала либо возврат воспаления.
The gap this hypothesis explains
Something is claimed here, but it rests on evidence too thin to carry weight.
Does temporarily silencing memory in tissue cells, blood-forming cells, or both stop inflammation returning after conditions improve?
Original wording · exactly as the pipeline generated it
Что возвращает воспаление после нормализации среды: автономная память тканевых клеток, память кроветворных предшественников или их взаимное подкрепление, выявляемое раздельным и совместным обратимым подавлением этих программ?
What this question is asking
The question asks where lasting changes that might restart inflammation are stored. It compares memory within tissue cells, memory in the blood-forming precursor cells that produce immune cells, and a cycle in which these two sources keep reactivating each other. The proposed comparison is between temporarily suppressing each memory program separately and suppressing both together after the original harmful conditions have been corrected. The question assumes that memory of physical conditions in tissue cells and inherited memory of altered cellular chemistry have already been demonstrated separately, but that their interaction in an aged organism remains unresolved. Its intended measure of success is recovery toward a common stable condition over weeks, followed by limited remaining loss of function during repeated challenges over months; the supplied material does not specify the challenges or acceptable limits.
- Inflammation
- A response involving immune cells and tissue signals to injury or harmful exposure. Here, the outcome is whether that response returns after the original harmful conditions are corrected.
- Cellular or inflammatory memory
- A lasting change caused by an earlier exposure that alters a cell's later behavior or the behavior of its descendants. It names a class of effects, not conscious memory or one universally defined program.
- Tissue cells and autonomous tissue-cell memory
- Tissue cells are cells within organs; the question contrasts them with blood-forming precursors. Autonomous memory would mean that a retained change within those tissue cells contributes to later behavior without continued exposure to the original trigger; it does not necessarily mean independence from every outside signal.
- Blood-forming stem and precursor cells
- Cells that give rise to blood cells, including immune cells. Stem cells can maintain their own population, while precursors are further along the path toward particular blood-cell types; memory in this compartment could affect subsequently produced cells.
- Immune cells
- Cells involved in defense and responses to damage. The question concerns whether their behavior reflects lasting changes in the cells that produced them.
- Mechanical memory
- A lasting cellular effect of earlier physical conditions, such as forces or the properties of surrounding material. The pipeline labels this component RL-1, but supplies no definition of that label or direct finding establishing the particular program.
- Metabolism and inherited metabolic memory
- Metabolism is the set of chemical processes through which cells obtain and use energy and materials. Inherited metabolic memory here means that effects of an earlier metabolic state persist in descendant cells, rather than inheritance between parents and offspring; the pipeline labels it RL-2 without defining that label.
- Memory program and reversible suppression
- A memory program is shorthand for cellular processes that maintain an exposure's lasting effects. Reversible suppression means temporarily reducing those processes and then allowing the suppressing effect to end; temporary improvement alone would not establish permanent removal of memory.
- Mutual reinforcement
- A cycle in which changes in one cell group help maintain or restore changes in another, which then acts back on the first. It is one of the possibilities being asked about, not a demonstrated relationship in the supplied evidence.
- Environmental correction
- Removal or correction of the harmful conditions thought to sustain inflammation. The input does not specify those conditions or a measurement confirming that they have been corrected.
- Functional deficit
- A remaining reduction in how well a tissue or organism works. The pipeline asks for this loss to remain limited, but supplies neither the function being measured nor its acceptable limit.
- Epithelial cells
- Cells that cover body surfaces and line internal spaces and organs. S3 identifies them as cells capable of acquiring memory.
- Cell-surface signaling protein
- A protein at a cell's surface that helps transmit signals into the cell when an activating partner binds. In S2, memory preserves such a protein, supporting continued responsiveness to activating signals.
- Neutrophils
- A type of immune cell produced from blood-forming cells. S8 measures their increased arrival in the abdominal cavity during a subsequent infection.
- Candida albicans
- The fungal species used for the earlier exposure and subsequent infection in S8. That result concerns a response to infection, rather than demonstrated spontaneous return of inflammation after environmental correction.
Mechanical memory in tissue cells and inherited metabolic memory in blood-forming precursors have been demonstrated separately, and their interaction in an aged organism has not been established.
Tissue cells are cells within an organ, while blood-forming precursors generate blood cells, including immune cells. The assumption is that the first group can retain effects of earlier physical conditions and the second can pass effects of altered cellular chemistry to its descendants. If established in the relevant setting, these would provide two distinct sources whose contributions to returning inflammation could be compared.
The sources support a narrower premise: lasting changes occur in some tissue-cell settings, and prior exposure of blood-forming cells can affect the responses of their descendants. S2 reports inflammatory memory in pancreatic cancer cells, and S3 reports that cells covering or lining body surfaces acquire memories in living organisms. S8 reports a changed response in immune cells descended from previously exposed blood-forming cells in mice. These findings do not establish the specific mechanical and inherited metabolic programs named in the pipeline statement, their persistence after environmental correction in aged organisms, or their mutual reinforcement. None of the supplied excerpts establishes their interaction; that limitation does not establish that the wider literature lacks such work.S2S3S8
The same question asked without the part nothing read establishes:
- After harmful conditions are corrected, does temporarily suppressing lasting changes in tissue cells, blood-forming precursors, or both prevent inflammation from returning?
- What evidence distinguishes tissue-cell memory from blood-forming-precursor memory as a source of returning inflammation after harmful conditions are corrected?
- Tissue-cell memory sustains recurrence Under this outcome, tissue cells would retain the change that restarts inflammation after their surroundings improve. Suppressing that memory would prevent recurrence under the conditions examined, while suppressing memory only in blood-forming precursors would leave the tissue source active.
- Blood-forming-precursor memory sustains recurrence Under this outcome, blood-forming precursors would continue producing immune cells with an altered response. Suppressing that precursor memory would prevent recurrence under the conditions examined, while suppressing tissue-cell memory alone would leave the continuing supply of altered immune cells.
- Both memories reinforce each other Under this outcome, activity arising from either cell group would help restore the altered state in the other. Separate temporary suppression would therefore permit recurrence, whereas joint suppression could interrupt the cycle; persistence of that interruption after suppression ends would determine whether recovery lasts.
- Neither proposed memory explains recurrence If recurrence continued despite effective joint suppression, these two memories would not sufficiently explain its return. The question's proposed choice between them would then leave the actual cause unresolved.
Correcting an ongoing source of inflammation and removing a lasting change caused by that source are different steps. If tissue cells retain a change that restarts inflammation, correcting their surroundings could leave that source of recurrence intact. If blood-forming precursors retain the relevant change, the immune cells they subsequently produce could instead carry the altered response forward. If the two sources reactivate each other, suppressing only one could allow the other to restore the cycle. These are conditional consequences of the question's proposed mechanism: confusing them could lead to mistaking temporary improvement for lasting recovery.
Механическая память RL-1 и наследуемая метаболическая память RL-2 показаны раздельно; их взаимодействие в старом организме не установлено.
После устранения стимула траектории сходятся за недели; остаточный функциональный дефицит остаётся ниже заданных границ при повторных нагрузках месяцами.
Неизвестно, какая память восстанавливает патологическое состояние после коррекции среды и достаточно ли устранения одного источника для устойчивого общего эффекта.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Предшествующее повреждение оставляет устойчивое изменение высоты и плотности поверхностных молекул на тканевых клетках и их остатках. При контакте с макрофагом расстояние между мембранами становится слишком большим для вытеснения фосфатазы CD45 из участка распознавания. Она продолжает снимать активирующие фосфатные группы, поэтому связанный клеточный материал поглощается плохо. Его повторное накопление возвращает воспаление после нормализации растворимых сигналов и жёсткости среды. Носитель остаточного состояния здесь представляет собой геометрия поверхности. Восстановление подходящего расстояния в фагоцитарном контакте должно разорвать цикл неполной очистки и повторного повреждения, стабилизируя SPV_6.
Where the idea comes from
The hypothesis borrows a result from another field. This is what it borrows, and from where.
Упаковка, геометрия и стерические ограничения: модель размерного исключения с больцмановским распределением. Проверяемое приближение: K = c_contact/c_free = exp[-ΔG_steric/(k_B T)], где ΔG_steric = κ[max(0,h-d)]²/2. Здесь K обозначает коэффициент распределения CD45 между контактом и свободной мембраной; c_contact и c_free являются его поверхностными концентрациями; h обозначает эффективную высоту внеклеточной части CD45; d является расстоянием между мембранами; κ обозначает эффективную жёсткость сжатия поверхностного слоя с размерностью энергия/длина²; k_B является постоянной Больцмана; T обозначает абсолютную температуру. При h>d стерическая цена снижает присутствие фосфатазы в контакте. Квадратичная зависимость служит приближением, параметры которого измеряются независимо. Размерная зависимость фагоцитоза экспериментально показана в [исследовании геометрического разделения молекул при фагоцитозе](https://pmc.ncbi.nlm.nih.gov/articles/PMC6067926/).
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
При одинаковых плотности лиганда, сродстве рецептора, составе клеток и текущей среде изменение только длины инертного молекулярного соединителя меняет присутствие CD45 в контакте, фосфорилирование рецептора и вероятность завершённого поглощения. Короткий контакт восстанавливает очистку и предотвращает последующее воспаление при сохранении прежних ядерных программ. Укорочение внеклеточной части CD45 должно отменять этот эффект, поскольку укороченная фосфатаза снова помещается в контакт. Отсутствие такой зависимости при подтверждённом изменении расстояния отвергает геометрическое объяснение.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable changes under controlled conditions, an intervention expected to abolish the effect, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Модельные мишени с заданной высотой антигена и макрофаги с изменённой внеклеточной частью CD45 позволяют проверять причинность независимо от изменения транскрипции. Затем требуется подтвердить тот же принцип на естественном клеточном материале: перенос результата с антителозависимого фагоцитоза на удаление погибших клеток пока является отдельным предположением.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
При одинаковых плотности лиганда, сродстве рецептора, составе клеток и текущей среде изменение только длины инертного молекулярного соединителя меняет присутствие CD45 в контакте, фосфорилирование рецептора и вероятность завершённого поглощения. Короткий контакт восстанавливает очистку и предотвращает последующее воспаление при сохранении прежних ядерных программ. Укорочение внеклеточной части CD45 должно отменять этот эффект, поскольку укороченная фосфатаза снова помещается в контакт. Отсутствие такой зависимости при подтверждённом изменении расстояния отвергает геометрическое объяснение.
- Rival 01 of 03What would separate them
Cell fusion may restart inflammation by combining tissue and immune programs in persistent hybrids predicts: После раздельного и совместного обратимого подавления тканевой и кроветворной программ воспаление возвращается преимущественно из клеток, в которых подтверждены геномы обеих линий. Удаление только этих клеток устраняет рецидив после повторной малой нагрузки; удаление такого же числа соседних негибридных клеток этого эффекта не даёт. Обнаружение устойчивого рецидива в культурах с надёжно исключённым слиянием и его устранение коррекцией геометрии контакта, редактирования РНК или матриксных пептидов опровергает гипотезу как основное объяснение.
- Rival 02 of 03What would separate them
Underedited ribonucleic acid may sustain inflammation through an interferon feedback loop predicts: В очищенных тканевых культурах после удаления иммунных клеток возвращению воспаления предшествуют рост конкретных недостаточно отредактированных двуцепочечных РНК и активация MDA5. Адресное разрушение этих транскриптов или восстановление каталитически активного ADAR1 предотвращает рецидив; каталитически неактивный вариант не предотвращает. Для доказательства хранения состояния краткое вмешательство должно давать эффект после своей отмены, а интерфероновая стимуляция должна воспроизводимо восстанавливать образование причинных транскриптов. Если редактирование нормализовано, но воспаление возвращается и устраняется только коррекцией контакта или матрикса, гипотеза отвергается.
- Rival 03 of 03Matrix breakdown may restart inflammation through a peptide-driven feedback loop
Not yet published.
What would separate themMatrix breakdown may restart inflammation through a peptide-driven feedback loop predicts: Бесклеточная пептидная фракция ранее повреждённой ткани запускает привлечение нейтрофилов в системе из клеток без прежней истории воздействия. Эффект исчезает после избирательного удаления PGP и возвращается при добавлении синтетического пептида в измеренной исходной концентрации. Замена клеток при сохранённом матриксе допускает рецидив; химическая обработка матрикса при сохранённых клетках предотвращает его. Сохранение эффекта после подтверждённого удаления причинных пептидов, особенно при зависимости от MDA5 или геометрии фагоцитарного контакта, опровергает гипотезу.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.